Insider · CIK 0001904163
Yehuda Eliya
Files at RAPH (Raphael Pharmaceutical Inc.). First filing -, latest -.
In brief
Yehuda Eliya files SEC Form 4 as director at RAPH (Raphael Pharmaceutical Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Yehuda Eliya has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 10, 2025 | RAPH Raphael Pharmaceutical Inc. | AGrant or award Warrant to purchase Common Stockderivative | +200,000 | $0.00 | $0 | 200,000 | Mar 12, 2025 |
| May 12, 2022 | RAPH Raphael Pharmaceutical Inc. | EExpiration of short derivative Warrant to purchase Common Stockderivative | -202,000 | $0.00 | $0 | 0 | Mar 12, 2025 |
| Nov 25, 2023 | RAPH Raphael Pharmaceutical Inc. | AGrant or award Common Stock | +150,000 | $0.40 | $60k | 352,000 | Mar 25, 2024 |
Questions about Yehuda Eliya
Answered from the filings on this page, as of the latest one.
Is Yehuda Eliya buying or selling?
Yehuda Eliya has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Yehuda Eliya's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Yehuda Eliya has 0.
Where does Yehuda Eliya file Form 4?
Yehuda Eliya has filed Form 4 at RAPH (Raphael Pharmaceutical Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.